Skip to main content
Premium Trial:

Request an Annual Quote

Devyser Diagnostics Fully Acquires Data Analysis Software Maker SmartSeq

NEW YORK — Swedish molecular diagnostics firm Devyser Diagnostics said on Monday that it has exercised an option to fully acquire SmartSeq, an Italian developer of data analysis software, for €835,000 ($942,500) in cash and stock.

SmartSeq offers Amplicon Suite, a software-as-a-service that enables genetic test data uploading, analysis, and interpretation, as well as results reporting. It is primarily sold to Devyser, which bundles it with a reagent kit, but also marketed to other customers.

Under the terms of the deal, Devyser acquired the remaining 70.1 percent of SmartSeq in exchange for €242,150 in cash and €592,850 in newly issued Devyser shares. In late 2018, Devyser paid €12,558 for 29.9 percent of SmartSeq and an option to buy the rest of the company.

"SmartSeq has a high degree of expertise in software development for data analysis and its software is a key component in our offering in genetic testing," Devyser CEO Fredrik Alpsten said in a statement. "The acquisition strengthens our gross margin as we can now supply the software ourselves instead of purchasing it from SmartSeq."

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.